Literature DB >> 30008895

Alteration of microRNA profiling in sphere-cultured ovarian carcinoma cells.

Hwa Jun Cha1,2, Sung Kwan An2, Tae Jin Kim3,4, Jae Ho Lee4.   

Abstract

Ovarian cancer is an aggressive and lethal cancer, which in part, can be attributed to complications in the effective detection of this disease during early stages of progression. Frequently, epithelial ovarian cancer is disseminated to the abdominal cavity and forms multicellular aggregates. This unique early metastatic event, and formation of the multicellular aggregate is implicated to provide a basis for understanding the underlying molecular mechanisms of metastasis in ovarian cancer. Therefore, a 3-dimensional (3D) sphere culture system was established in the present study to mimic the later stages of ovarian cancer. The aim of the present study was to investigate whether microRNAs (miRNAs), which have functions in metastasis and chemoresistance in various cancer models, are altered in ovarian cancer cells by 3-dimensional (3D) culture. A multicellular aggregate of SKOV3ip1 ovarian carcinoma cells was generated using a 3D sphere culture system. Cell viability analysis demonstrated that the sphere-cultured SKOV3ip1 cells exhibited chemoresistance compared with those in a conventional 2-dimensional (2D) monolayer cultured SKOV3ip1 system. Under the same experimental conditions, 71 upregulated miRNAs and 63 downregulated miRNAs were identified in the 3D sphere-cultured SKOV3ip1 cells. The predicted targets of the 3D sphere-culture specific miRNAs were further identified using PITA, microRNAorg and TargetScan. Compared with the target gene pool and Kyoto Encyclopedia of Genes and Genomes pathway, the present study provides evidence that the 3D sphere culture-specific miRNAs regulated sphere formation and chemoresistance in 3D sphere-cultured SKOV3ip1 cells. Overall, the results of the present study demonstrated that miRNA-mediated regulation is implicated to provoke features of SKOV3ip1 multicellular aggregation, including sphere formation and chemoresistance.

Entities:  

Keywords:  3-dimensional sphere culture systems; chemoresistance; microRNA; ovarian cancer

Year:  2018        PMID: 30008895      PMCID: PMC6036436          DOI: 10.3892/ol.2018.8818

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

Review 1.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

2.  MicroRNA biogenesis and cellular proliferation.

Authors:  Divya Lenkala; Eric R Gamazon; Bonnie LaCroix; Hae Kyung Im; R Stephanie Huang
Journal:  Transl Res       Date:  2015-02-07       Impact factor: 7.012

Review 3.  Cancer of the ovary.

Authors:  Stephen A Cannistra
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

4.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

Review 5.  Expression profiles of genes involved in poor prognosis of epithelial ovarian carcinoma: a review.

Authors:  Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Mariko Sakata; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Int J Gynecol Cancer       Date:  2009-08       Impact factor: 3.437

6.  Molecular architecture of a miRNA-regulated 3' UTR.

Authors:  Dominic Didiano; Oliver Hobert
Journal:  RNA       Date:  2008-05-07       Impact factor: 4.942

7.  Distant metastases in ovarian carcinoma.

Authors:  G Cormio; C Rossi; A Cazzolla; L Resta; G Loverro; P Greco; L Selvaggi
Journal:  Int J Gynecol Cancer       Date:  2003 Mar-Apr       Impact factor: 3.437

8.  MicroRNA-mediated drug resistance in breast cancer.

Authors:  Kristy R Kutanzi; Olga V Yurchenko; Frederick A Beland; Vasyl' F Checkhun; Igor P Pogribny
Journal:  Clin Epigenetics       Date:  2011-06-27       Impact factor: 6.551

9.  TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer.

Authors:  Ning Wang; Hui Zhang; Qin Yao; Yankui Wang; Shuzhen Dai; Xingsheng Yang
Journal:  J Exp Clin Cancer Res       Date:  2012-01-16

10.  HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.

Authors:  J R Ribeiro; C Schorl; N Yano; N Romano; K K Kim; R K Singh; R G Moore
Journal:  J Ovarian Res       Date:  2016-05-17       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.